// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The development of generic versions of innovator medicines is a global public health need.
Quality assurance is a wide-ranging concept encompassing all factors that collectively influence
When it comes to good distribution practices (GDPs) for medical products, patient safety is the h